Business Context and Reporting Period
This Form 6-K filing by Icecure Medical Ltd. covers the month of December 2022, specifically dated December 21, 2022. The report serves to furnish press releases regarding a public offering of common stock priced at-the-market under Nasdaq rules.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures for the reporting period. The primary financial data point disclosed is the pricing of a public offering totaling $14.5 million.
Material Changes
The material change reported is the execution of a $14.5 million public offering. This follows a proposed public offering announced on December 20, 2022. No comparative financial performance data against prior periods is included in this specific filing.
Guidance, Outlook, and Risks
The filing incorporates press releases by reference but does not contain explicit management commentary on future guidance, operational outlook, or specific risk factors within the text provided. The offering was conducted under Nasdaq rules, implying adherence to standard market regulations for at-the-market offerings.
Investor Verification Checklist
- Verify the final number of shares issued to raise the $14.5 million.
- Confirm the use of proceeds from the offering as detailed in the referenced press releases (Exhibits 99.1 and 99.2).
- Review the Company's Registration Statements on Form F-3 (Nos. 333-258660 and 333-267272) for updated capitalization tables.
- Check subsequent filings for any dilution impact on existing shareholders.